1260 results
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
DPP-4 Inhibitors ... Action: Inhibits DPP ... Januvia) - Once/day tablet ... Onglyza) - Once/day tablet ... Tradjenta) - Once/day tablet
Burn Wound Assessment - Classification Table #Diagnosis #Clinical #Burn #Classification #Table #Epidermal #Superficial
Wound Assessment - Classification ... Table #Diagnosis ... Clinical #Burn #Classification ... #Table #Epidermal
Antiarrhythmic Medication Table

#Antiarrhythmic #Medications #Table #Classification #Classes #Cardiology #Pharmacology
Antiarrhythmic Medication Table ... #Medications #Table ... #Classification
Classification of the Cardiomyopathies - Dilated, Hypertrophic, and Restrictive

#Cardiomyopathy #Classification #Table #Comparison #Cardiology #Diagnosis
Classification of ... Cardiomyopathy #Classification ... #Table #Comparison
Diabetes Combination Tablets - Estimated A1c Lowering 
Metformin + DPP4 
• Janumet (metformin + sitagliptin) 
•
Metformin + DPP4 ... dapagliflozin) Dpp4
Primary and Secondary Headache Types - Differential Classification

- By Dr. Eric Strong @DrEricStrong

#Headaches #Primary #Secondary #Types
- Differential Classification ... Differential #Diagnosis #Classification ... #Table
Cardiogenic Shock Forrester Classification Table and Mortality

- Warm & Dry (Forrester Class I)

- Warm & Wet
Shock Forrester Classification ... Table and Mortality ... Shock #Forrester #Classification ... CHF #Diagnosis #Table
Hyperparathyroidism classification
Different causes and features of hyperparathyroidism - raised parathormone (PTH).

#Diagnosis #Hyperparathyroidism #Differential #Primary #Secondary #Tertiary
Hyperparathyroidism classification ... Tertiary #Comparison #Table ... #Classification
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... linagliptin) 5 mg DPP4 ... lower dose of a DPP4 ... /ambcarerx #DPP4
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Medications Summary Table ... events TZDs DPP ... #medications #table